Pramipexole News and Research

RSS
New study supports motor cortex 'excitability' as cause of restless legs syndrome

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Impulse control disorders found to be more common in people taking Parkinson's drugs

Impulse control disorders found to be more common in people taking Parkinson's drugs

Parkinson's disease medications could lead to impulse control disorders

Parkinson's disease medications could lead to impulse control disorders

New treatment strategy may take pain away

New treatment strategy may take pain away

Pharma Two B reports positive results from P2B001 Phase IIb study for treatment of early stage PD

Pharma Two B reports positive results from P2B001 Phase IIb study for treatment of early stage PD

Non-ergot derived dopamine agonists may be safe for the heart

Non-ergot derived dopamine agonists may be safe for the heart

FDA-approved drug pregabalin effectively treats RLS symptoms with less side effects

FDA-approved drug pregabalin effectively treats RLS symptoms with less side effects

Parkinson's disease drugs may lead to impulse control disorders

Parkinson's disease drugs may lead to impulse control disorders

Dopamine agonists used in treatment of Parkinson's disease may lead to impulse control disorders

Dopamine agonists used in treatment of Parkinson's disease may lead to impulse control disorders

Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets

Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets

Study suggests treating RLS may improve sleep and quality of life in people with fibromyalgia

Study suggests treating RLS may improve sleep and quality of life in people with fibromyalgia

Teva second-quarter net sales increase 12% to $3.8 billion

Teva second-quarter net sales increase 12% to $3.8 billion

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Teva reports 31% increase in non-GAAP net income for first-quarter 2010

Teva reports 31% increase in non-GAAP net income for first-quarter 2010

Pramipexole ER uptake to be inhibited by availability of generic version

Pramipexole ER uptake to be inhibited by availability of generic version

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

New systematic study for managing treatment-resistant bipolar depression

New systematic study for managing treatment-resistant bipolar depression